HL074190/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	4
2009	5
2010	2
2011	8
2012	6
2013	4
2014	7
2015	2
2017	1
2019	1
2024	0

1

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.

Vanichakarn P, Hwa J, Stitham J. Vanichakarn P, et al. Curr Mol Med. 2014;14(7):849-79. doi: 10.2174/1566524014666140811115517. Curr Mol Med. 2014. PMID: 25109793 Review.

2

Shp shape: FAKs about hypertrophy.

Martin KA, Hwa J. Martin KA, et al. Circ Res. 2008 Oct 10;103(8):776-8. doi: 10.1161/CIRCRESAHA.108.186452. Circ Res. 2008. PMID: 18845815 Free PMC article. No abstract available.

3

An eicosanoid-centric view of atherothrombotic risk factors.

Gleim S, Stitham J, Tang WH, Martin KA, Hwa J. Gleim S, et al. Cell Mol Life Sci. 2012 Oct;69(20):3361-80. doi: 10.1007/s00018-012-0982-9. Epub 2012 Apr 11. Cell Mol Life Sci. 2012. PMID: 22491820 Free PMC article. Review.

4

Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.

Stitham J, Vanichakarn P, Ying L, Hwa J. Stitham J, et al. Curr Mol Med. 2014;14(7):909-31. doi: 10.2174/1566524014666140811121109. Curr Mol Med. 2014. PMID: 25109796 Review.

5

The human prostacyclin receptor from structure function to disease.

Martin KA, Gleim S, Elderon L, Fetalvero K, Hwa J. Martin KA, et al. Prog Mol Biol Transl Sci. 2009;89:133-66. doi: 10.1016/S1877-1173(09)89006-6. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374736 Review.

6

Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity.

Liu R, Jin Y, Tang WH, Qin L, Zhang X, Tellides G, Hwa J, Yu J, Martin KA. Liu R, et al. Circulation. 2013 Oct 29;128(18):2047-57. doi: 10.1161/CIRCULATIONAHA.113.002887. Epub 2013 Sep 27. Circulation. 2013. PMID: 24077167 Free PMC article.

7

Prostacyclin: an inflammatory paradox.

Stitham J, Midgett C, Martin KA, Hwa J. Stitham J, et al. Front Pharmacol. 2011 May 13;2:24. doi: 10.3389/fphar.2011.00024. eCollection 2011. Front Pharmacol. 2011. PMID: 21687516 Free PMC article.

8

Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Gleim S, Kasza Z, Martin K, Hwa J. Gleim S, et al. Curr Atheroscler Rep. 2009 May;11(3):227-35. doi: 10.1007/s11883-009-0035-5. Curr Atheroscler Rep. 2009. PMID: 19361355 Review.

9

Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease.

Ibrahim S, Tetruashvily M, Frey AJ, Wilson SJ, Stitham J, Hwa J, Smyth EM. Ibrahim S, et al. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1802-9. doi: 10.1161/ATVBAHA.110.208900. Epub 2010 Jun 3. Arterioscler Thromb Vasc Biol. 2010. PMID: 20522800 Free PMC article.

10

Prostacyclin receptor regulation--from transcription to trafficking.

Midgett C, Stitham J, Martin K, Hwa J. Midgett C, et al. Curr Mol Med. 2011 Oct;11(7):517-28. doi: 10.2174/156652411800615144. Curr Mol Med. 2011. PMID: 21707517 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year